ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)

  1. Winthrop, K.L.
  2. Mariette, X.
  3. Silva, J.T.
  4. Benamu, E.
  5. Calabrese, L.H.
  6. Dumusc, A.
  7. Smolen, J.S.
  8. Aguado, J.M.
  9. Fernández-Ruiz, M.
Revista:
Clinical Microbiology and Infection

ISSN: 1469-0691,  1198-743X

Any de publicació: 2018

Volum: 24

Pàgines: S21-S40

Tipus: Revisió

DOI: 10.1016/J.CMI.2018.02.002 GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible

Font de les dades: Scopus